National Aerospace Fasteners Corporation (3004) Fair Value & Analysis
Industrials · TW · Market cap 8.6B TWD
Fair value as of: Jun 24, 2026
Analysis
National Aerospace Fasteners Corporation (3004) currently trades at 132.00 TWD, while our model-based Fair Value estimate is 98.12 TWD — implying the stock looks roughly 25.7% overvalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
National Aerospace Fasteners Corporation manufactures and sells fasteners and structural components for aircraft, ships, and vehicles in Taiwan and internationally. The company offers aero products, including bolts; nuts, such as hex nuts, 10 PT nuts, double hex nuts, spline nuts kits, shank nuts, gang channels, and anchor nuts; CNC products comprising tubes, stampings, links, latches, and fittings; and other products consisting of adapters, brackets, bushings, clamps, flanges, guides, housings, inertial dampers, pins, fixing plates, retainers, seals, sleeves, spacers, weights, etc. It also provides rivet studs, brass inserts, blind rivet nuts, machining and customized parts, and high-temperature nuts for automotive applications. The company was incorporated in 1997 and is based in Taoyuan City, Taiwan.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is National Aerospace Fasteners Corporation (3004) undervalued?
What is the fair value of 3004?
What is the quality score of 3004?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.